Introduction to a Supplement on Innovative Approaches to Studying Health Outcomes in Rare Diseases

The authors introduce a journal supplement highlighting the growing importance of rare diseases in health policy and the need for innovative research methods, noting that rare disease drugs are increasingly approved on weaker evidence and that novel approaches to trial design, patient registries, and outcome measurement are needed.